Viewing Study NCT06287268

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 5:56 PM
Ignite Modification Date: 2026-02-01 @ 4:15 PM
Study NCT ID: NCT06287268
Status: RECRUITING
Last Update Posted: 2025-01-14
First Post: 2024-02-22
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: Revolade Tablets Specified Drug-use Survey
Sponsor: Novartis Pharmaceuticals
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Aplastic Anemia View
Keywords:

Keywords

Keyword Brief Keyword Text View
None NIS View
None Pediatric Aplastic Anemia View
None AA View
None Revolade Tablets View
None eltrombopag View
None Drug-use Survey View